Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
Todd M. Pitts(The Medical Center of Aurora), Stephen Leong(University of Colorado Cancer Center)
Cited by 52
Related Papers
The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
|Clinical Cancer Research|2010|44